RESPIRATORY TESTING
For in vitro diagnostic use. Rx only.
STAY AHEAD OF EVOLVING VARIANTS AND SEASONAL SURGES WITH ABBOTT’S RESPIRATORY PORTFOLIO.
Respiratory testing demand can shift quickly during seasonal surges and outbreak periods. Abbott’s Alinity m Resp-4-Plex assay helps laboratories respond with high-throughput molecular testing that supports workflow efficiency and operational flexibility.
ASSAYS
ALINITY M RESP-4-PLEX ASSAY
Alinity m Resp-4-Plex delivers differentiated results of SARS-CoV-2, flu A, flu B and RSV with one sample, on Alinity m, a high-throughput, flexible system.
GLOBALLY MONITORED AGAINST EMERGING VARIANTS
Abbott Pandemic Defense Coalition (APDC) is the first-of-its-kind global network dedicated to identifying, tracing and responding to disease outbreaks.
APDC has analyzed 250 SARS-CoV-2 variants against Alinity m Resp-4-Plex and Alinity m SARS-CoV-2, finding mutations have no impact on assay performance.
NEED HELP OPTIMIZING YOUR LAB’S
WORKFLOW FROM SAMPLE TO RESULT?
Talk to your Molecular sales representative to learn more.
EXPLORE
Alinity m System
Deliver critical lab results faster, run any test at any time and process high volumes with the Alinity m system.
Transplant Care
Support post-transplant care with automated viral load testing and the workflow flexibility laboratories need to prioritize urgent samples and deliver timely results.
Hepatitis and Retrovirus
Deliver confidence in HBV, HCV, and HIV-1 testing with reliable detection across evolving viral landscapes, backed by the Abbott Pandemic Defense Coalition.